cbdMD, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on March 12, 2021, regarding cbdMD, Inc. (NYSE American: YCBD). The filing details the results of the company's 2021 Annual Meeting of Shareholders and subsequent board appointments. The company is designated as an emerging growth company.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent 10-K or 10-Q filings for financial statements.
Material Changes and Corporate Actions
The filing reports the following material corporate actions:
- Shareholder Voting: A quorum was established with 34,803,091 shares (66.6% of outstanding shares) represented. All four proposals submitted to shareholders were approved.
- Director Elections: Seven directors were elected to serve until the 2022 annual meeting. While all were approved, significant "Broker Non-Votes" (7,751,239 shares) were recorded for each director.
- Executive Appointments: Following the meeting, the Board reappointed Martin A. Sumichrast as Chairman and co-CEO, R. Scott Coffman as co-CEO and President, and T. Ronan Kennedy as CFO, Secretary, and Treasurer.
- Committee Appointments: New committee chairs and members were assigned, including William F. Raines, III as Audit Committee Chairman and Bakari Sellers as Compensation Committee Chairman.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or discussion of specific risks and contingencies. It strictly reports on the procedural outcomes of the annual meeting and board reorganization.
Key Facts for Investor Verification
- Verify the specific terms of the newly approved 2021 Equity Compensation Plan (Proposal 3) to understand potential dilution impacts.
- Note the high volume of Broker Non-Votes (approx. 7.75 million shares) on director elections, which may indicate brokerages did not have discretionary voting authority on these matters.
- Confirm the ratification of Cherry Bekaert LLP as the independent registered public accounting firm.
- Review the definitive proxy statement (Schedule 14A filed January 25, 2021) for detailed biographies of the elected directors and executive compensation specifics.